Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: H&R GmbH & Co KgaA

Market Cap 179M 205M 165M 155M 291M 19.34B 292M 1.96B 761M 9.52B 769M 753M 33.05B P/E 2026 *
30.5x
P/E 2027 * 22.5x
Enterprise Value 335M 384M 310M 290M 544M 36.23B 548M 3.68B 1.43B 17.83B 1.44B 1.41B 61.92B EV / Sales 2026 *
0.26x
EV / Sales 2027 * 0.25x
Free-Float
22.35%
Yield 2026 *
1.04%
Yield 2027 * 1.04%
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-14 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25-08-24 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
25-08-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-15 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
25-05-13 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-16 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
25-04-08 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-26 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
25-03-26 H&R GmbH & Co. KGaA Announces Postponement of the Publication of the Consolidated Financial Statements and the Annual Report 2024 CI
Manager TitleAgeSince
Chief Executive Officer 61 2015-12-31
Investor Relations Contact - 2005-12-31
Director TitleAgeSince
Chairman 62 2012-04-16
Director/Board Member 71 2011-04-30
Director/Board Member 69 2011-04-30
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 205M
-1.77%-2.46%+1.25%+22.99% 120B
-1.36%-1.99%0.00%-38.48% 43.32B
+9.88%+30.52%+399.10%+75.95% 34.83B
-2.46%-3.66%+29.31%-24.86% 31.94B
-2.76%-6.88%+28.80%+67.39% 23.11B
-0.16%+8.50%+494.18%+708.00% 20.69B
-2.75%-2.53%+122.88%+8.46% 19.85B
-2.82%-6.98%+2.44%-34.88% 19.39B
-4.04%-2.06%+20.59%+17.20% 17.78B
Average -0.82%+1.56%+122.06%+89.09% 36.71B
Weighted average by Cap. -0.77%+1.19%+86.94%+57.30%

Financials

2026 *2027 *
Net sales 1.29B 1.48B 1.2B 1.12B 2.1B 140B 2.12B 14.21B 5.51B 68.9B 5.57B 5.45B 239B 1.33B 1.53B 1.23B 1.15B 2.16B 144B 2.18B 14.62B 5.66B 70.86B 5.73B 5.6B 246B
Net income 5.85M 6.71M 5.42M 5.07M 9.51M 633M 9.57M 64.26M 24.9M 312M 25.18M 24.64M 1.08B 8M 9.17M 7.4M 6.93M 13M 865M 13.08M 87.84M 34.04M 426M 34.42M 33.68M 1.48B
Net Debt 156M 179M 145M 135M 254M 16.89B 255M 1.72B 665M 8.32B 672M 658M 28.87B 158M 181M 146M 137M 257M 17.08B 258M 1.73B 672M 8.41B 679M 665M 29.19B
Logo H&R GmbH & Co KgaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!